Prevalence of human T cell lymphotropic virus 1 infection in Canada

doi:10.3747/co.26.4593

. 2019 Feb;26(1):e3-e5.

doi: 10.3747/co.26.4593. Epub 2019 Feb 1.

Prevalence of human T cell lymphotropic virus 1 infection in Canada

L Amar¹, M Le¹, F M Ghazawi², E Rahme¹, A Segal¹, E Netchiporouk¹, G Popradi¹, L Moreau¹, O Roshdy¹, D Sasseville¹, I V Litvinov¹

Affiliations

PMID: 30853802
PMCID: PMC6380656
DOI: 10.3747/co.26.4593

Free PMC article

Prevalence of human T cell lymphotropic virus 1 infection in Canada

L Amar et al. Curr Oncol. 2019 Feb.

Free PMC article

. 2019 Feb;26(1):e3-e5.

doi: 10.3747/co.26.4593. Epub 2019 Feb 1.

Authors

L Amar¹, M Le¹, F M Ghazawi², E Rahme¹, A Segal¹, E Netchiporouk¹, G Popradi¹, L Moreau¹, O Roshdy¹, D Sasseville¹, I V Litvinov¹

Affiliations

¹ Division of Dermatology, McGill University, Montreal, QC.
² Division of Dermatology, University of Ottawa, Ottawa, ON.

PMID: 30853802
PMCID: PMC6380656
DOI: 10.3747/co.26.4593

No abstract available

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST DISCLOSURES We have read and understood Current Oncology’s policy on disclosing conflicts of interest, and we declare that we have none.

Cited by

A Qualitative Study Exploring Perceptions to the Human T Cell Leukaemia Virus Type 1 in Central Australia: Barriers to Preventing Transmission in a Remote Aboriginal Population.
Fowler F, Einsiedel L. Fowler F, et al. Front Med (Lausanne). 2022 Apr 29;9:845594. doi: 10.3389/fmed.2022.845594. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35572972 Free PMC article.
Incidence and Mortality of Prostate Cancer in Canada during 1992-2010.
Lagacé F, Ghazawi FM, Le M, Savin E, Zubarev A, Powell M, Moreau L, Sasseville D, Popa I, Litvinov IV. Lagacé F, et al. Curr Oncol. 2021 Feb 21;28(1):978-990. doi: 10.3390/curroncol28010096. Curr Oncol. 2021. PMID: 33617514 Free PMC article.
Investigating epidemiologic trends and the geographic distribution of patients with anal squamous cell carcinoma throughout Canada.
Cattelan L, Ghazawi FM, Le M, Savin E, Zubarev A, Lagacé F, Sasseville D, Waschke K, Litvinov IV. Cattelan L, et al. Curr Oncol. 2020 Jun;27(3):e294-e306. doi: 10.3747/co.27.6061. Epub 2020 Jun 1. Curr Oncol. 2020. PMID: 32669936 Free PMC article.
Epidemiology of adult and pediatric Burkitt lymphoma in Canada: sequelae of the HIV epidemic.
Roy SF, Ghazawi FM, Le M, Lagacé F, Roy CF, Rahme E, Savin E, Zubarev A, Sasseville D, Popradi G, Litvinov IV. Roy SF, et al. Curr Oncol. 2020 Apr;27(2):83-89. doi: 10.3747/co.27.5775. Epub 2020 May 1. Curr Oncol. 2020. PMID: 32489250 Free PMC article.
Epidemiologic trends and geographic distribution of esophageal cancer in Canada: A national population-based study.
Cattelan L, Ghazawi FM, Le M, Lagacé F, Savin E, Zubarev A, Gantchev J, Tomaszewski M, Sasseville D, Waschke K, Litvinov IV. Cattelan L, et al. Cancer Med. 2020 Jan;9(1):401-417. doi: 10.1002/cam4.2700. Epub 2019 Nov 12. Cancer Med. 2020. PMID: 31715645 Free PMC article.

See all "Cited by" articles

References

1. Carneiro-Proietti AB, Catalan-Soares BC, Castro-Costa CM, et al. htlv in the Americas: challenges and perspectives. Rev Panam Salud Publica. 2006;19:44–53. doi: 10.1590/S1020-49892006000100007. - DOI - PubMed
1. Goncalves DU, Proietti FA, Ribas JG, et al. Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1–associated diseases. Clin Microbiol Rev. 2010;23:577–89. doi: 10.1128/CMR.00063-09. - DOI - PMC - PubMed
1. Satake M, Yamaguchi K, Tadokoro K. Current prevalence of htlv-1 in Japan as determined by screening of blood donors. J Med Virol. 2012;84:327–35. doi: 10.1002/jmv.23181. - DOI - PubMed
1. O’Brien SF, Goldman M, Scalia V, et al. The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors. Transfus Med. 2013;23:358–66. - PubMed
1. Murphy EL, Hanchard B, Figueroa JP, et al. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer. 1989;43:250–3. doi: 10.1002/ijc.2910430214. - DOI - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources

[1] Carneiro-Proietti AB, Catalan-Soares BC, Castro-Costa CM, et al. htlv in the Americas: challenges and perspectives. Rev Panam Salud Publica. 2006;19:44–53. doi: 10.1590/S1020-49892006000100007. - DOI - PubMed

[2] Carneiro-Proietti AB, Catalan-Soares BC, Castro-Costa CM, et al. htlv in the Americas: challenges and perspectives. Rev Panam Salud Publica. 2006;19:44–53. doi: 10.1590/S1020-49892006000100007. - DOI - PubMed

[3] Goncalves DU, Proietti FA, Ribas JG, et al. Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1–associated diseases. Clin Microbiol Rev. 2010;23:577–89. doi: 10.1128/CMR.00063-09. - DOI - PMC - PubMed

[4] Goncalves DU, Proietti FA, Ribas JG, et al. Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1–associated diseases. Clin Microbiol Rev. 2010;23:577–89. doi: 10.1128/CMR.00063-09. - DOI - PMC - PubMed

[5] Satake M, Yamaguchi K, Tadokoro K. Current prevalence of htlv-1 in Japan as determined by screening of blood donors. J Med Virol. 2012;84:327–35. doi: 10.1002/jmv.23181. - DOI - PubMed

[6] Satake M, Yamaguchi K, Tadokoro K. Current prevalence of htlv-1 in Japan as determined by screening of blood donors. J Med Virol. 2012;84:327–35. doi: 10.1002/jmv.23181. - DOI - PubMed

[7] O’Brien SF, Goldman M, Scalia V, et al. The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors. Transfus Med. 2013;23:358–66. - PubMed

[8] O’Brien SF, Goldman M, Scalia V, et al. The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors. Transfus Med. 2013;23:358–66. - PubMed

[9] Murphy EL, Hanchard B, Figueroa JP, et al. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer. 1989;43:250–3. doi: 10.1002/ijc.2910430214. - DOI - PubMed

[10] Murphy EL, Hanchard B, Figueroa JP, et al. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer. 1989;43:250–3. doi: 10.1002/ijc.2910430214. - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Prevalence of human T cell lymphotropic virus 1 infection in Canada

Affiliations

Prevalence of human T cell lymphotropic virus 1 infection in Canada

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources